FDA Publishes Letter to Health Care Providers Regarding Blood Culture Media Bottle Shortage
BD Life Sciences notified customers in June to expect a shortage of its BD BACTECTM blood culture bottles and intends to provide ongoing updates. The United States Food and Drug Association (FDA) is working closely with this supplier and published a letter to health care providers on July 10, 2024. In this letter, the FDA recommends that health care providers develop strategies to prioritize the use of blood culture media bottles based on clinical need.
To prepare for and adapt to shortages, consult the following webpages for recommendations and resources:
- BD BACTECTM Blood Culture Vial Supply
- Disruptions in Availability of BD BACTEC Blood Culture Media Bottles – FDA Letter to Health Care Providers
- American Society for Clinical Pathology (ASCP) Webinar and Resources for Imminent BD Blood Culture Media Bottle Shortage
